Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Mexico seeks low-risk NAFTA minor-crop agchems

Mexico proposes to participate in stimulating the development and registration of “reduced-risk” pesticides, particularly on minor crops with its NAFTA colleagues. The Ministry of Agriculture’s food quality and health service, the Senasica, has presented the NAFTA Technical Working Group (TWG) with a project to finance pesticide efficacy studies on six crops of interest. They are cacti, citrus fruit, herbs, onions, papayas and pineapples. The crops cover some 724,000 ha, and are worth around Peso 33.5 million ($2.4 million). The Ministry indicates that it will be looking at approvals of chemical pesticides and biopesticides, and cites the TWG’s strengthening international reputation and its successful previous work-sharing in pesticide registrations as reasons for following this route. The TWG agreed to establish a pilot programme for a trilateral review for a new use of a registered pesticide last year ( Agrow No 608, p 13). The Mexican authorities have recently indicated a move towards the use and availability of more “lower risk” pesticides in the country ( Agrow No 629, p 19).



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts